Non-hormonal treatment for hot flashes
If estrogen is off the table, you can still get hot flashes under control. Three non-hormonal prescriptions cut them by about half. All three are generics. A licensed clinician reviews your intake and sends the one that fits to your pharmacy.
The three are venlafaxine, oxybutynin and low-dose paroxetine. Pick the one you want, or answer a few questions and let the clinician choose.
One fact decides a lot. If you take tamoxifen, venlafaxine and oxybutynin are safe with it, and paroxetine is not, because paroxetine can blunt how well tamoxifen works. The intake asks, and routes you to a safe choice.
What it treats
Moderate to severe hot flashes and night sweats, for women who have a reason to avoid estrogen or simply prefer not to take it. Common reasons include:
- A history of breast cancer, including women taking tamoxifen or an aromatase inhibitor.
- A history of blood clots, a clotting disorder, stroke or heart disease.
- A history of endometrial or another estrogen-sensitive cancer.
- Hormone therapy that was not tolerated, or did not control symptoms enough.
- A personal preference to avoid hormones.
Your treatment options
One intake covers all three. A clinician confirms the fit and prescribes a three-month supply. You usually feel the effect within one to two weeks, with the full effect by about four weeks.
- Venlafaxine XRonce daily
- An SNRI, used off-label for hot flashes. Start at 37.5 mg for a week, then 75 mg, the target dose. The preferred choice if you take tamoxifen. Don't stop suddenly; we taper you off.
- Oxybutynintwice daily
- A bladder medicine, used off-label for hot flashes, and neither an antidepressant nor a hormone. Start at 2.5 mg, stepping to 5 mg if needed; a 15 mg once-daily form is an alternative. Safe with tamoxifen.
- Low-dose paroxetineonce daily
- An SSRI at a low dose, and the one medicine the FDA approved for hot flashes (sold as Brisdelle 7.5 mg, now generic paroxetine). Not used if you take tamoxifen. Don't stop suddenly; we taper you off.
- Supply and refills
- First fill is a three-month supply. A check-in at week 4 to 6 covers how it is working and any dose change. Refills then run up to twelve months with an annual renewal.
These medicines treat the hot flashes. They do not treat the condition that made estrogen unsafe, and they do not replace your oncology, heart or clotting care.
What the evidence says
These lower hot flashes by about half. Estrogen lowers them by about three quarters. Half fewer is real relief, and the trial numbers back it up.
- [1]
Venlafaxine works about as well as low-dose estrogen. In a head-to-head randomized trial, venlafaxine 75 mg cut hot flash frequency by 48% against 53% for low-dose estradiol. The 5-point gap was not statistically significant (Joffe, JAMA Internal Medicine 2014). Pooled trial data put venlafaxine, escitalopram and low-dose estradiol at roughly a 50% reduction versus about 30% for placebo (Guthrie, Obstetrics & Gynecology 2015).
- [2]
Oxybutynin is competitive with the antidepressants. In a placebo-controlled trial in women who could not take estrogen, 65% of them on tamoxifen or an aromatase inhibitor, oxybutynin 5 mg twice daily cut weekly hot flash frequency by 7.5 against 2.6 for placebo (Leon-Ferre, ACCRU trial, JNCI Cancer Spectrum 2020).
- [3]
Low-dose paroxetine is FDA-approved, with a modest effect. Two randomized trials supported approval of paroxetine 7.5 mg for hot flashes, with a statistically significant but modest reduction over placebo, sustained to 24 weeks (Simon, Menopause 2013). Its effect is at the lower end of this group.
- [4]
Tamoxifen is the reason the choice matters. Tamoxifen needs the liver enzyme CYP2D6 to turn into its active form. Paroxetine strongly blocks that enzyme, and a population study linked paroxetine and tamoxifen together to higher breast cancer death (Kelly, BMJ 2010). Venlafaxine barely affects the enzyme and is the preferred antidepressant for hot flashes in women on tamoxifen (Desmarais, Journal of Clinical Psychiatry 2009).
Known risks and side effects
Each medicine has its own profile. None needs routine blood tests. The questions in the intake screen for the situations below.
Venlafaxine and paroxetine
- Do not combine with an MAOI. Taking venlafaxine or paroxetine within two weeks of an MAOI (phenelzine, tranylcypromine, selegiline, linezolid) can cause a dangerous reaction. The intake stops this combination.
- Do not stop suddenly. Stopping abruptly can cause dizziness, brain-zaps, nausea and irritability. We taper you down when you want to stop.
- Serotonin syndrome and bleeding. Combining with other serotonin-raising medicines (another antidepressant, tramadol, lithium) needs review. These also slightly raise bleeding risk with a blood thinner, aspirin or a daily anti-inflammatory.
- Blood pressure, for venlafaxine. Venlafaxine can nudge blood pressure up, so a reading from the past six months is required. A reading of 160/100 or higher routes you to oxybutynin or paroxetine instead.
- Paroxetine and tamoxifen. Paroxetine is not used if you take tamoxifen, because it can lower tamoxifen's effect. The intake routes tamoxifen users to venlafaxine or oxybutynin.
Oxybutynin
- Anticholinergic effects. Dry mouth is common, along with constipation and dry eyes. They are dose-related and often ease over time.
- Not safe with narrow-angle glaucoma or urinary retention. Oxybutynin can raise eye pressure and worsen trouble emptying the bladder or a slow gut. The intake stops it in these cases and routes you to another option.
- Long-term anticholinergic use and memory. Large studies in older adults link high cumulative use of anticholinergic medicines over years to a higher risk of dementia (Gray, JAMA Internal Medicine 2015; Coupland, JAMA Internal Medicine 2019). That signal is from long-term, high-dose use in older people, not from short courses, but it is the reason to use the lowest effective dose, keep courses defined and avoid stacking other anticholinergic medicines.
These are not used in pregnancy or while breastfeeding. If you have thoughts of harming yourself, call or text 988 any time; you do not have to wait for us.
Choosing between the three
You can pick an option or ask the clinician to choose. A simple way to think about it:
If you take tamoxifen, venlafaxine or oxybutynin. Paroxetine is off the table because it can lower tamoxifen's effect. An aromatase inhibitor does not have this problem, so any of the three is fine on one.
If you would rather not take an antidepressant, oxybutynin. It works about as well and is neither a hormone nor an antidepressant. It is not used if you have narrow-angle glaucoma or trouble emptying your bladder.
If you also have low mood, anxiety or poor sleep, venlafaxine often helps more than one thing at once. The intake includes a brief mood screen, and a positive screen routes you to a clinician for a proper look rather than a low dose for hot flashes alone.
How it works here
You answer an intake. Questions about your hot flashes, why you are avoiding estrogen, whether you take tamoxifen, and the safety questions for the option you want. About ten minutes. Disqualifying answers stop the flow before you pay.
A licensed clinician reviews it. Most reviews finish within one business day. If you asked us to choose, the clinician selects the safest fit and explains why.
The pharmacy ships a three-month supply. A check-in at week 4 to 6 covers how it is working and any dose change. Refills unlock after that, then continue with an annual renewal.
Price
Two flat charges: the visit and the medication. No membership.
| Clinical visit and prescription | $39 |
|---|---|
| Venlafaxine (three-month supply) | $49 |
| Oxybutynin (three-month supply) | $55 |
| Low-dose paroxetine (three-month supply) | $45 |
These are evidence-based prescription medications, dispensed by licensed pharmacies.
FAQ
Do these work as well as hormone therapy?
Almost. Estrogen lowers hot flashes by about three quarters. These lower them by about half. In a head-to-head trial, venlafaxine 75 mg and low-dose estradiol were not significantly different. For many women who can't take estrogen, half fewer hot flashes is a real change.
I take tamoxifen. Which one is safe?
Venlafaxine or oxybutynin. Both are safe with tamoxifen. Paroxetine is not used with tamoxifen because it blocks the enzyme that turns tamoxifen into its active form, and that has been linked to worse breast cancer outcomes. The intake asks about tamoxifen and routes you accordingly. Aromatase inhibitors do not have this issue.
Is oxybutynin an antidepressant?
No. Oxybutynin is normally used for an overactive bladder. It is used off-label for hot flashes and works about as well as the antidepressants, without being one. It is a good option if you would rather not take an antidepressant, as long as you do not have narrow-angle glaucoma or trouble emptying your bladder.
Why isn't Veozah or Lynkuet offered here?
Both are newer non-hormonal options that work well. Veozah (fezolinetant) carries a boxed warning for liver injury and needs repeated blood tests, which does not fit an online model. Both are brand-only and cost several hundred dollars a month, with savings programs that do not apply to cash-pay. We may add one if a generic arrives.
How long until they work?
Faster than you might expect. Most women feel a difference within one to two weeks, with the full effect by about four weeks. If a medicine is not helping by then, we adjust the dose or switch.
Can I stop whenever I want?
Yes, but taper rather than stop cold for venlafaxine and paroxetine, because stopping suddenly can cause dizziness and other withdrawal effects. Message us and we step you down. Oxybutynin can be stopped without a taper.
From the catalog · Non-hormonal hot flash treatment
Start your intake
Answer the intake and a licensed clinician reviews it, usually within one business day. Pick an option or ask us to choose.
Clinical content reviewed by [Reviewer name], MD. Last clinically reviewed 2026-06-15.